|
 Gene ontology annotations for ACTB |
|
|
| Experiment description of studies that identified ACTB in sEVs |
| 1 |
| Experiment ID |
79 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20458337
|
| Organism |
Homo sapiens |
| Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 1 |
| Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
| Journal name |
ICB
|
| Publication year |
2010 |
| Sample |
B cells |
| Sample name |
RN (HLA-DR15) |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient
Immunobeads (MHC Class II) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [FT-ICR]
Western blotting |
|
|
| 2 |
| Experiment ID |
80 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20458337
|
| Organism |
Homo sapiens |
| Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis -Sample 2 |
| Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
| Journal name |
ICB
|
| Publication year |
2010 |
| Sample |
B cells |
| Sample name |
RN (HLA-DR15) |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient
Immunobeads (MHC Class II) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [FT-ICR]
Western blotting |
|
|
| 3 |
| Experiment ID |
81 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD81|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20458337
|
| Organism |
Homo sapiens |
| Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 3 |
| Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
| Journal name |
ICB
|
| Publication year |
2010 |
| Sample |
B cells |
| Sample name |
RN (HLA-DR15) |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient
Immunobeads (MHC Class II) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [FT-ICR]
Western blotting |
|
|
| 4 |
| Experiment ID |
76 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|GAPDH|HSP90|CD81|CD9|CD63|LAMP1|MHCI
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
20224111
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomics analysis of bladder cancer exosomes. |
| Authors |
"Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A." |
| Journal name |
MCP
|
| Publication year |
2010 |
| Sample |
Bladder cancer cells |
| Sample name |
HT1376 |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient |
| Flotation density |
1.10-1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF/TOF]
Western blotting
FACS |
|
|
| 5 |
| Experiment ID |
489 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 6 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 6 |
| Experiment ID |
490 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 7 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 7 |
| Experiment ID |
491 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 8 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 8 |
| Experiment ID |
492 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
|
✔
Canx
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Rattus norvegicus |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Bone marrow mesenchymal stem cells |
| Sample name |
BMSC - Passage 9 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 9 |
| Experiment ID |
19 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
16302729
|
| Organism |
Homo sapiens |
| Experiment description |
"Purification, characterization and biological significance of tumor-derived exosomes." |
| Authors |
"Koga K, Matsumoto K, Akiyoshi T, Kubo M, Yamanaka N, Tasaki A, Nakashima H, Nakamura M, Kuroki S, Tanaka M, Katano M" |
| Journal name |
ACR
|
| Publication year |
2005 |
| Sample |
Breast cancer cells |
| Sample name |
BT-474
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient
Filtration
Immunobeads(HER2) |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
FACS |
|
|
| 10 |
| Experiment ID |
65 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
HSP60|HSP27|GAPDH|FLOT2
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
Western blotting
|
| PubMed ID |
19415654
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. |
| Authors |
"Staubach S, Razawi H, Hanisch FG." |
| Journal name |
PROTEOMICS
|
| Publication year |
2009 |
| Sample |
Breast cancer cells |
| Sample name |
MCF-7 |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF]
Western blotting |
|
|
| 11 |
| Experiment ID |
397 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|TSG101|CD63
|
Enriched markers |
|
✔
GOLGA2|CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
33738083
|
| Organism |
Homo sapiens |
| Experiment description |
Bioorthogonally surface-edited extracellular vesicles based on metabolic glycoengineering for CD44-mediated targeting of inflammatory diseases |
| Authors |
"Lim GT, You DG, Han HS, Lee H, Shin S, Oh BH, Kumar EKP, Um W, Kim CH, Han S, Lee S, Lim S, Yoon HY, Kim K, Kwon IC, Jo DG, Cho YW, Park JH" |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Immunofluorescence
Flow cytomtery |
|
|
| 12 |
| Experiment ID |
398 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|TSG101|CD63
|
Enriched markers |
|
✔
GOLGA2|CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
33738083
|
| Organism |
Homo sapiens |
| Experiment description |
Bioorthogonally surface-edited extracellular vesicles based on metabolic glycoengineering for CD44-mediated targeting of inflammatory diseases |
| Authors |
"Lim GT, You DG, Han HS, Lee H, Shin S, Oh BH, Kumar EKP, Um W, Kim CH, Han S, Lee S, Lim S, Yoon HY, Kim K, Kwon IC, Jo DG, Cho YW, Park JH" |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Immunofluorescence
Flow cytomtery |
|
|
| 13 |
| Experiment ID |
412 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD9|CD63|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX|ACTB
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Breast cancer cells |
| Sample name |
MCF7 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
mRNA |
| Methods used in the study |
RT-qPCR
Western blotting
Mass spectrometry
Flow cytometry |
|
|
| 14 |
| Experiment ID |
1181 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|CD81|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 15 |
| Experiment ID |
1182 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|CD81|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 16 |
| Experiment ID |
1183 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 1 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
1.05 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 17 |
| Experiment ID |
1184 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 5 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 18 |
| Experiment ID |
1185 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 6 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 19 |
| Experiment ID |
1186 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 7 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 20 |
| Experiment ID |
1187 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 8 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 21 |
| Experiment ID |
1188 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 9 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 22 |
| Experiment ID |
1192 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 5 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 23 |
| Experiment ID |
1193 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 6 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 24 |
| Experiment ID |
1194 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 7 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 25 |
| Experiment ID |
1195 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 8 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 26 |
| Experiment ID |
1196 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 - Fraction 9 |
| Isolation/purification methods |
Differential centrifugation
OptiPrep density gradient centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 27 |
| Experiment ID |
1197 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD81|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 28 |
| Experiment ID |
1198 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|CD81|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32848136
|
| Organism |
Homo sapiens |
| Experiment description |
ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells |
| Authors |
"Fuentes P, Sesé M, Guijarro PJ, Emperador M, Sánchez-Redondo S, Peinado H, Hümmer S, Ramón Y Cajal S." |
| Journal name |
Nat Commun
|
| Publication year |
2020 |
| Sample |
Breast cancer cells |
| Sample name |
MDA-MB-231 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 29 |
| Experiment ID |
1334 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35918900
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL) |
| Authors |
"Bauzá-Martinez J, Armony G, Pronker MF, Wu W. " |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2022 |
| Sample |
Breast cancer cells |
| Sample name |
LM2 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectometry |
|
|
| 30 |
| Experiment ID |
1334 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35918900
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL) |
| Authors |
"Bauzá-Martinez J, Armony G, Pronker MF, Wu W. " |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2022 |
| Sample |
Breast cancer cells |
| Sample name |
LM2 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectometry |
|
|
| 31 |
| Experiment ID |
1334 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35918900
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL) |
| Authors |
"Bauzá-Martinez J, Armony G, Pronker MF, Wu W. " |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2022 |
| Sample |
Breast cancer cells |
| Sample name |
LM2 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectometry |
|
|
| 32 |
| Experiment ID |
1334 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35918900
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL) |
| Authors |
"Bauzá-Martinez J, Armony G, Pronker MF, Wu W. " |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2022 |
| Sample |
Breast cancer cells |
| Sample name |
LM2 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectometry |
|
|
| 33 |
| Experiment ID |
1336 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35918900
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL) |
| Authors |
"Bauzá-Martinez J, Armony G, Pronker MF, Wu W. " |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2022 |
| Sample |
Breast cancer cells |
| Sample name |
LM2 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectometry |
|
|
| 34 |
| Experiment ID |
1336 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35918900
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL) |
| Authors |
"Bauzá-Martinez J, Armony G, Pronker MF, Wu W. " |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2022 |
| Sample |
Breast cancer cells |
| Sample name |
LM2 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectometry |
|
|
| 35 |
| Experiment ID |
1336 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35918900
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL) |
| Authors |
"Bauzá-Martinez J, Armony G, Pronker MF, Wu W. " |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2022 |
| Sample |
Breast cancer cells |
| Sample name |
LM2 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectometry |
|
|
| 36 |
| Experiment ID |
1336 |
| MISEV standards |
|
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35918900
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL) |
| Authors |
"Bauzá-Martinez J, Armony G, Pronker MF, Wu W. " |
| Journal name |
J Extracell Vesicles
|
| Publication year |
2022 |
| Sample |
Breast cancer cells |
| Sample name |
LM2 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectometry |
|
|
| 37 |
| Experiment ID |
46 |
| MISEV standards |
|
✔
EM|IEM
|
Biophysical techniques |
|
✔
HSC70|CD63|MHCII|CD81|CD86
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
17641064
|
| Organism |
Homo sapiens |
| Experiment description |
Exosomes with immune modulatory features are present in human breast milk. |
| Authors |
"Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S" |
| Journal name |
JIMMU
|
| Publication year |
2007 |
| Sample |
Breast milk |
| Sample name |
Breast milk - Colostrum |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose density gradient |
| Flotation density |
1.10-1.18 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QSTAR]
Western blotting
Immunoelectron Microscopy
FACS |
|
|
| 38 |
| Experiment ID |
48 |
| MISEV standards |
|
✔
EM|IEM
|
Biophysical techniques |
|
✔
HSC70|CD63|CD86|MHCII
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
17641064
|
| Organism |
Homo sapiens |
| Experiment description |
Exosomes with immune modulatory features are present in human breast milk. |
| Authors |
"Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S" |
| Journal name |
JIMMU
|
| Publication year |
2007 |
| Sample |
Breast milk |
| Sample name |
Breast milk - Mature milk |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose density gradient |
| Flotation density |
1.10-1.18 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QSTAR]
Western blotting
Immunoelectron Microscopy
FACS |
|
|
| 39 |
| Experiment ID |
388 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|CD9
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
33767144
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells |
| Authors |
"Bonsergent E, Grisard E, Buchrieser J, Schwartz O, Théry C, Lavieu G." |
| Journal name |
Nat Commun
|
| Publication year |
2021 |
| Sample |
Cervical cancer cells |
| Sample name |
HeLa |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 40 |
| Experiment ID |
494 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD81|CD151|CD63|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35931686
|
| Organism |
Homo sapiens |
| Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
| Authors |
"Varela-EirÃn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Chondrocytes |
| Sample name |
Osteoarthritic cartilage |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 41 |
| Experiment ID |
496 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35931686
|
| Organism |
Homo sapiens |
| Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
| Authors |
"Varela-EirÃn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Chondrocytes |
| Sample name |
Healthy cartilage |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 42 |
| Experiment ID |
497 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35931686
|
| Organism |
Homo sapiens |
| Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
| Authors |
"Varela-EirÃn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Chondrocytes |
| Sample name |
T/C-28a2 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 43 |
| Experiment ID |
498 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35931686
|
| Organism |
Homo sapiens |
| Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
| Authors |
"Varela-EirÃn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
| Journal name |
Cell Death Dis
|
| Publication year |
2022 |
| Sample |
Chondrocytes |
| Sample name |
T/C-28a2 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 44 |
| Experiment ID |
20 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP90|CD63|CD81|LAMP1
|
Enriched markers |
|
✔
GOLGA2|cytochrome c
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
Western blotting
|
| PubMed ID |
17956143
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of microvesicles derived from human colorectal cancer cells. |
| Authors |
"Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP, Gho YS" |
| Journal name |
JPR
|
| Publication year |
2007 |
| Sample |
Colorectal cancer cells |
| Sample name |
HT29 |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient
Diafiltration |
| Flotation density |
1.16 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [LTQ]
Western blotting |
|
|
| 45 |
| Experiment ID |
21 |
| MISEV standards |
|
✔
EM|IEM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD63
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
19837982
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic and bioinformatic analysis of immunoaffinity-purified exosomes derived from the human colon tumor cell line LIM1215. |
| Authors |
"Suresh Mathivanan, Justin W.E. Lim, Bow J. Tauro, Hong Ji, Robert L. Moritz and Richard J. Simpson" |
| Journal name |
MCP
|
| Publication year |
2009 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1215 |
| Isolation/purification methods |
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.10-1.12 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [Orbitrap]
Western blotting |
|
|
| 46 |
| Experiment ID |
201 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22740476
|
| Organism |
Homo sapiens |
| Experiment description |
Restoration of full-length APC protein in SW480 colon cancer cells induces exosome-mediated secretion of DKK-4. |
| Authors |
"Lim JW, Mathias RA, Kapp EA, Layton MJ, Faux MC, Burgess AW, Ji H, Simpson RJ." |
| Journal name |
Electrophoresis
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
SW480 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 47 |
| Experiment ID |
207 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
|
✔
VDAC
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23161513
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
| Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
| Journal name |
Mol Cell Proteomics
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
DKO-1 |
| Isolation/purification methods |
Differential centrifugation
Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 48 |
| Experiment ID |
208 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
|
✔
VDAC
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23161513
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
| Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
| Journal name |
Mol Cell Proteomics
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
Dks-8 |
| Isolation/purification methods |
Differential centrifugation
Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 49 |
| Experiment ID |
209 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
|
✔
VDAC
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23161513
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
| Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
| Journal name |
Mol Cell Proteomics
|
| Publication year |
2012 |
| Sample |
Colorectal cancer cells |
| Sample name |
DLD-1 |
| Isolation/purification methods |
Differential centrifugation
Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 50 |
| Experiment ID |
271 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
25907253
|
| Organism |
Homo sapiens |
| Experiment description |
Rapid and comprehensive 'shotgun' lipidome profiling of colorectal cancer cell derived exosomes. |
| Authors |
"Lydic TA, Townsend S, Adda CG, Collins C, Mathivanan S, Reid GE." |
| Journal name |
Methods
|
| Publication year |
2015 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1215 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Lipids
Protein |
| Methods used in the study |
Mass spectrometry
Western blotting |
|
|
| 51 |
| Experiment ID |
282 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
DLS
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25890246
|
| Organism |
Homo sapiens |
| Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
| Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
| Journal name |
Methods
|
| Publication year |
2015 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1863 - Ultracentrifugation - Rep 1 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Centrifugal concentration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry
Western blotting |
|
|
| 52 |
| Experiment ID |
283 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
DLS
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25890246
|
| Organism |
Homo sapiens |
| Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
| Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
| Journal name |
Methods
|
| Publication year |
2015 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1863 - Ultracentrifugation - Rep 2 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Centrifugal concentration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry
Western blotting |
|
|
| 53 |
| Experiment ID |
285 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
DLS
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25890246
|
| Organism |
Homo sapiens |
| Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
| Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
| Journal name |
Methods
|
| Publication year |
2015 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1863 - Sequential centrifugal ultrafiltration - Rep 1 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sequential centrifugal ultrafiltration
Centrifugal concentration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry
Western blotting |
|
|
| 54 |
| Experiment ID |
286 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
DLS
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25890246
|
| Organism |
Homo sapiens |
| Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
| Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
| Journal name |
Methods
|
| Publication year |
2015 |
| Sample |
Colorectal cancer cells |
| Sample name |
LIM1863 - Sequential centrifugal ultrafiltration - Rep 2 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sequential centrifugal ultrafiltration
Centrifugal concentration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry
Western blotting |
|
|
| 55 |
| Experiment ID |
1203 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
SDCBP|FLOT1|CD9|CD81|CD63|EPCAM|GAPDH|LAMP1|TFRC|CD151|CD82|LAMP2|RAB35|TSG101|FLOT2|RAB5B|ICAM1|RAB5A
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34887515
|
| Organism |
Homo sapiens |
| Experiment description |
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets |
| Authors |
"Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Colorectal cancer cells |
| Sample name |
DiFi |
| Isolation/purification methods |
Differential centrifugation
Filtration
Centrifugal ultrafiltration
Ultracentrifugation
OptiPrep density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
miRNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RNA sequencing |
|
|
| 56 |
| Experiment ID |
1203 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
SDCBP|FLOT1|CD9|CD81|CD63|EPCAM|GAPDH|LAMP1|TFRC|CD151|CD82|LAMP2|RAB35|TSG101|FLOT2|RAB5B|ICAM1|RAB5A
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
34887515
|
| Organism |
Homo sapiens |
| Experiment description |
Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets |
| Authors |
"Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Colorectal cancer cells |
| Sample name |
DiFi |
| Isolation/purification methods |
Differential centrifugation
Filtration
Centrifugal ultrafiltration
Ultracentrifugation
OptiPrep density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
miRNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RNA sequencing |
|
|
| 57 |
| Experiment ID |
305 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD63|CD81|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
33431899
|
| Organism |
Homo sapiens |
| Experiment description |
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance |
| Authors |
"Kumar A, Sundaram K, Mu J, Dryden GW, Sriwastva MK, Lei C, Zhang L, Qiu X, Xu F, Yan J, Zhang X, Park JW, Merchant ML, Bohler HCL, Wang B, Zhang S, Qin C, Xu Z, Han X, McClain CJ, Teng Y, Zhang HG." |
| Journal name |
Nat Commun
|
| Publication year |
2021 |
| Sample |
Faeces |
| Sample name |
Healthy volunteers |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
Lipid |
| Methods used in the study |
Western blotting
Mass spectrometry
Immunofluorescence
HPLC |
|
|
| 58 |
| Experiment ID |
306 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
CD63|CD81|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
33431899
|
| Organism |
Homo sapiens |
| Experiment description |
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance |
| Authors |
"Kumar A, Sundaram K, Mu J, Dryden GW, Sriwastva MK, Lei C, Zhang L, Qiu X, Xu F, Yan J, Zhang X, Park JW, Merchant ML, Bohler HCL, Wang B, Zhang S, Qin C, Xu Z, Han X, McClain CJ, Teng Y, Zhang HG." |
| Journal name |
Nat Commun
|
| Publication year |
2021 |
| Sample |
Faeces |
| Sample name |
Type 2 diabetes patients |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
Lipid |
| Methods used in the study |
Western blotting
Mass spectrometry
Immunofluorescence
HPLC |
|
|
| 59 |
| Experiment ID |
363 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
|
✔
DCLK1
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
33991177
|
| Organism |
Homo sapiens |
| Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
| Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
| Journal name |
Proteomics
|
| Publication year |
2021 |
| Sample |
Gastric cancer cells |
| Sample name |
MKN1 - 100K pellet |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 60 |
| Experiment ID |
364 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
|
✔
DCLK1
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
33991177
|
| Organism |
Homo sapiens |
| Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
| Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
| Journal name |
Proteomics
|
| Publication year |
2021 |
| Sample |
Gastric cancer cells |
| Sample name |
MKN1 - 100K pellet |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 61 |
| Experiment ID |
365 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
|
✔
DCLK1
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
33991177
|
| Organism |
Homo sapiens |
| Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
| Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
| Journal name |
Proteomics
|
| Publication year |
2021 |
| Sample |
Gastric cancer cells |
| Sample name |
MKN1 - 100K pellet |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 62 |
| Experiment ID |
760 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36581340
|
| Organism |
Homo sapiens |
| Experiment description |
"Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer" |
| Authors |
"Nambara S, Masuda T, Hirose K, Hu Q, Tobo T, Ozato Y, Kurashige J, Hiraki Y, Hisamatsu Y, Iguchi T, Sugimachi K, Oki E, Yoshizumi T, Mimori K." |
| Journal name |
Cancer Genomics Proteomics
|
| Publication year |
2023 |
| Sample |
Gastric cancer cells |
| Sample name |
58As9 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 63 |
| Experiment ID |
761 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36581340
|
| Organism |
Homo sapiens |
| Experiment description |
"Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer" |
| Authors |
"Nambara S, Masuda T, Hirose K, Hu Q, Tobo T, Ozato Y, Kurashige J, Hiraki Y, Hisamatsu Y, Iguchi T, Sugimachi K, Oki E, Yoshizumi T, Mimori K." |
| Journal name |
Cancer Genomics Proteomics
|
| Publication year |
2023 |
| Sample |
Gastric cancer cells |
| Sample name |
58As9 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 64 |
| Experiment ID |
762 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63
|
Enriched markers |
|
✔
ACTB
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
36581340
|
| Organism |
Homo sapiens |
| Experiment description |
"Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer" |
| Authors |
"Nambara S, Masuda T, Hirose K, Hu Q, Tobo T, Ozato Y, Kurashige J, Hiraki Y, Hisamatsu Y, Iguchi T, Sugimachi K, Oki E, Yoshizumi T, Mimori K." |
| Journal name |
Cancer Genomics Proteomics
|
| Publication year |
2023 |
| Sample |
Gastric cancer cells |
| Sample name |
58As9 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 65 |
| Experiment ID |
234 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
mRNA
|
| Identification method |
RNA Sequencing
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocellular carcinoma cells |
| Sample name |
HKCI-C3 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RT-PCR
RNA Sequencing |
|
|
| 66 |
| Experiment ID |
235 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
mRNA
|
| Identification method |
RNA Sequencing
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocellular carcinoma cells |
| Sample name |
HKCI-8 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RT-PCR
RNA Sequencing |
|
|
| 67 |
| Experiment ID |
236 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
mRNA
|
| Identification method |
RNA Sequencing
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocellular carcinoma cells |
| Sample name |
MHCC97L |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RT-PCR
RNA Sequencing |
|
|
| 68 |
| Experiment ID |
234 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocellular carcinoma cells |
| Sample name |
HKCI-C3 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RT-PCR
RNA Sequencing |
|
|
| 69 |
| Experiment ID |
235 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocellular carcinoma cells |
| Sample name |
HKCI-8 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RT-PCR
RNA Sequencing |
|
|
| 70 |
| Experiment ID |
236 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocellular carcinoma cells |
| Sample name |
MHCC97L |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RT-PCR
RNA Sequencing |
|
|
| 71 |
| Experiment ID |
237 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
mRNA
|
| Identification method |
RNA Sequencing
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocytes |
| Sample name |
MIHA |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RNA Sequencing |
|
|
| 72 |
| Experiment ID |
237 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✔
qNano
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
26054723
|
| Organism |
Homo sapiens |
| Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
| Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
| Journal name |
Carcinogenesis
|
| Publication year |
2015 |
| Sample |
Hepatocytes |
| Sample name |
MIHA |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.19 g/mL
|
| Molecules identified in the study |
Protein
RNA |
| Methods used in the study |
Western blotting
Mass spectrometry
RNA Sequencing |
|
|
| 73 |
| Experiment ID |
4 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
CD63|MHCI|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
11487543
|
| Organism |
Homo sapiens |
| Experiment description |
Intestinal epithelial cells secrete exosome-like vesicles. |
| Authors |
"van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, Heyman M" |
| Journal name |
Not applicable
|
| Publication year |
2001 |
| Sample |
Intestinal epithelial cells |
| Sample name |
HT29-19A
T84-DRB1*0401/CIITA |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF]
Western blotting |
|
|
| 74 |
| Experiment ID |
189 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
19530224
|
| Organism |
Homo sapiens |
| Experiment description |
Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. |
| Authors |
"Chavez-Muñoz C, Kilani RT, Ghahary A." |
| Journal name |
J Cell Physiol
|
| Publication year |
2009 |
| Sample |
Keratinocytes |
| Sample name |
Keratinocytes - Differentiated |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose cushion
Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 75 |
| Experiment ID |
190 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSC70
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
19530224
|
| Organism |
Homo sapiens |
| Experiment description |
Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. |
| Authors |
"Chavez-Muñoz C, Kilani RT, Ghahary A." |
| Journal name |
J Cell Physiol
|
| Publication year |
2009 |
| Sample |
Keratinocytes |
| Sample name |
Keratinocytes - Undifferentiated |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose cushion
Filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 76 |
| Experiment ID |
330 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
32132711
|
| Organism |
Homo sapiens |
| Experiment description |
Decoy exosomes provide protection against bacterial toxins |
| Authors |
"Keller MD, Ching KL, Liang FX, Dhabaria A, Tam K, Ueberheide BM, Unutmaz D, Torres VJ, Cadwell K." |
| Journal name |
Nature
|
| Publication year |
2020 |
| Sample |
Lung cancer cells |
| Sample name |
A549 - 100K pellet |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 77 |
| Experiment ID |
417 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD81|CD63|SDCBP|LAMP1|CD9|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX|ACTB
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Lymphoma cells |
| Sample name |
Raji |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
mRNA |
| Methods used in the study |
RT-qPCR
Western blotting
Mass spectrometry
Flow cytometry |
|
|
| 78 |
| Experiment ID |
51 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP90|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
14975938
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes isolated from human malignant pleural effusions. |
| Authors |
"Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN" |
| Journal name |
AJRCMB
|
| Publication year |
2004 |
| Sample |
Malignant pleural effusions |
| Sample name |
Pleural Fluid - Breast cancer |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF]
Western blotting |
|
|
| 79 |
| Experiment ID |
52 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP90|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
14975938
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes isolated from human malignant pleural effusions. |
| Authors |
"Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN" |
| Journal name |
AJRCMB
|
| Publication year |
2004 |
| Sample |
Malignant pleural effusions |
| Sample name |
Pleural Fluid - Lung cancer |
| Isolation/purification methods |
Differential centrifugation
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF]
Western blotting |
|
|
| 80 |
| Experiment ID |
12 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
MHCI
|
Enriched markers |
|
✔
CANX|cytochrome c
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
15478216
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. |
| Authors |
"Mears R, Craven RA, Hanrahan S, Totty N, Upton C, Young SL, Patel P, Selby PJ, Banks RE" |
| Journal name |
PROTEOMICS
|
| Publication year |
2004 |
| Sample |
Melanoma cells |
| Sample name |
MeWo
SK-MEL-28 |
| Isolation/purification methods |
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.20 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [4700 Proteomics Analyzer]
Western blotting |
|
|
| 81 |
| Experiment ID |
200 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|TSG101|Alix|GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22635005
|
| Organism |
Homo sapiens |
| Experiment description |
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. |
| Authors |
"Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D." |
| Journal name |
Nat Med
|
| Publication year |
2012 |
| Sample |
Melanoma cells |
| Sample name |
B16-F10
SK-MEL-202
SK-MEL035
SK-MEL-265 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose cushion |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 82 |
| Experiment ID |
254 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
MNT-1 |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 83 |
| Experiment ID |
255 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
G1 |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 84 |
| Experiment ID |
256 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
501mel |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 85 |
| Experiment ID |
257 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
Daju |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 86 |
| Experiment ID |
258 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
SKMEL28 |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 87 |
| Experiment ID |
259 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
A375M |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 88 |
| Experiment ID |
260 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|FLOT1|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25950383
|
| Organism |
Homo sapiens |
| Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
| Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
| Journal name |
Pigment Cell Melanoma Res
|
| Publication year |
2015 |
| Sample |
Melanoma cells |
| Sample name |
1205Lu |
| Isolation/purification methods |
Differential centrifugation
Unltracentrifugation
Sucrose density gradient |
| Flotation density |
1.13 - 1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 89 |
| Experiment ID |
1115 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34957415
|
| Organism |
Homo sapiens |
| Experiment description |
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism |
| Authors |
"GarcÃa-Silva S, Benito-MartÃn A, Nogués L, Hernández-Barranco A, Mazariegos MS, Santos V, Hergueta-Redondo M, Ximénez-Embún P, Kataru RP, Lopez AA, Merino C, Sánchez-Redondo S, Graña-Castro O, Matei I, Nicolás-Avila JÃ, Torres-Ruiz R, RodrÃguez-Perales S, MartÃnez L, Pérez-MartÃnez M, Mata G, Szumera-Ciećkiewicz A, Kalinowska I, Saltari A, MartÃnez-Gómez JM, Hogan SA, Saragovi HU, Ortega S, Garcia-Martin C, Boskovic J, Levesque MP, Rutkowski P, Hidalgo A, Muñoz J, MegÃas D, Mehrara BJ, Lyden D, Peinado H." |
| Journal name |
Nat Cancer
|
| Publication year |
2021 |
| Sample |
Melanoma cells |
| Sample name |
SK-MEL-147 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 90 |
| Experiment ID |
1116 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34957415
|
| Organism |
Homo sapiens |
| Experiment description |
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism |
| Authors |
"GarcÃa-Silva S, Benito-MartÃn A, Nogués L, Hernández-Barranco A, Mazariegos MS, Santos V, Hergueta-Redondo M, Ximénez-Embún P, Kataru RP, Lopez AA, Merino C, Sánchez-Redondo S, Graña-Castro O, Matei I, Nicolás-Avila JÃ, Torres-Ruiz R, RodrÃguez-Perales S, MartÃnez L, Pérez-MartÃnez M, Mata G, Szumera-Ciećkiewicz A, Kalinowska I, Saltari A, MartÃnez-Gómez JM, Hogan SA, Saragovi HU, Ortega S, Garcia-Martin C, Boskovic J, Levesque MP, Rutkowski P, Hidalgo A, Muñoz J, MegÃas D, Mehrara BJ, Lyden D, Peinado H." |
| Journal name |
Nat Cancer
|
| Publication year |
2021 |
| Sample |
Melanoma cells |
| Sample name |
SK-MEL-147 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting |
|
|
| 91 |
| Experiment ID |
126 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
GAPDH
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry [LTQ-FT Ultra]
|
| PubMed ID |
Unpublished / Not applicable
|
| Organism |
Homo sapiens |
| Experiment description |
Mesenchymal Stem Cell Exosomes: The Future MSC-based Therapy? |
| Authors |
"Ruenn Chai Lai, Ronne Wee Yeh Yeo, Soon Sim Tan, Bin Zhang, Yijun Yin, Newman Siu Kwan Sze, Andre Choo, and Sai Kiang Lim" |
| Journal name |
Mesenchymal Stem Cell Therapy
|
| Publication year |
2011 |
| Sample |
Mesenchymal stem cells |
| Sample name |
huES9.E1 |
| Isolation/purification methods |
HPLC |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Antobody array
Mass spectrometry |
|
|
| 92 |
| Experiment ID |
488 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD81|CD63|GAPDH|SDCBP|LAMP1|TFRC|UCHL1|FLOT2|LAMP2|FLOT1|ICAM1|RAB5B|CD151|RAB35|TSG101|RAB5A|CD82
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
36408942
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
| Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
| Journal name |
Proteomics
|
| Publication year |
2023 |
| Sample |
Mesenchymal stem cells |
| Sample name |
UCMSC |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectometry |
|
|
| 93 |
| Experiment ID |
25 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
HSP90|beta-tubulin
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
15111327
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of exosomes secreted by human mesothelioma cells. |
| Authors |
"Hegmans JP, Bard MP, Hemmes A, Luider TM, Kleijmeer MJ, Prins JB, Zitvogel L, Burgers SA, Hoogsteden HC, Lambrecht BN." |
| Journal name |
AJP
|
| Publication year |
2004 |
| Sample |
Mesothelioma cells |
| Sample name |
PMR-MM7
PMR-MM8 |
| Isolation/purification methods |
Differential centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [MALDI TOF]
Western blotting |
|
|
| 94 |
| Experiment ID |
224 |
| MISEV standards |
|
✔
EM|AFM
|
Biophysical techniques |
|
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
|
✔
GOLGA2
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25944692
|
| Organism |
Homo sapiens |
| Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
| Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
| Journal name |
Oncotarget
|
| Publication year |
2015 |
| Sample |
Neuroblastoma cells |
| Sample name |
SH-SY5Y |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
OptiPrep density gradient |
| Flotation density |
1.10 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry
Western blotting |
|
|
| 95 |
| Experiment ID |
211 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
|
✔
cytochrome c|GOLGA2
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23333927
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
| Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
| Journal name |
J Proteomics
|
| Publication year |
2013 |
| Sample |
Ovarian cancer cells |
| Sample name |
IGROV1 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.09-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 96 |
| Experiment ID |
212 |
| MISEV standards |
|
✔
CEM
|
Biophysical techniques |
|
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
|
✔
Cytochrome C|GOLGA2
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
23333927
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
| Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
| Journal name |
J Proteomics
|
| Publication year |
2013 |
| Sample |
Ovarian cancer cells |
| Sample name |
OVCAR-3 |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.09-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 97 |
| Experiment ID |
408 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD9|CD63|CD81|SDCBP|LAMP1|GAPDH|FLOT1|TFRC|FLOT2|TSG101|RAB35
|
Enriched markers |
|
✔
CANX|ACTB
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
34108659
|
| Organism |
Homo sapiens |
| Experiment description |
Quantitative Proteomics Identifies the Core Proteome of Exosomes with Syntenin-1 as the highest abundant protein and a Putative Universal Biomarker |
| Authors |
"Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R." |
| Journal name |
Nat Cell Biol
|
| Publication year |
2021 |
| Sample |
Pancreatic duct epithalial cells |
| Sample name |
HPDE |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein
mRNA |
| Methods used in the study |
RT-qPCR
Western blotting
Mass spectrometry
Flow cytometry |
|
|
| 98 |
| Experiment ID |
231 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✔
Alix|CD63|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25332113
|
| Organism |
Homo sapiens |
| Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
| Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
| Journal name |
Transfusion
|
| Publication year |
2015 |
| Sample |
Platelets |
| Sample name |
PL-Exs - Rep 1 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Optiprep density gradient |
| Flotation density |
1.12-1.15 g/mL
|
| Molecules identified in the study |
Protein
Lipids |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 99 |
| Experiment ID |
232 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25332113
|
| Organism |
Homo sapiens |
| Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
| Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
| Journal name |
Transfusion
|
| Publication year |
2015 |
| Sample |
Platelets |
| Sample name |
PL-Exs - Rep 2 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Optiprep density gradient |
| Flotation density |
1.12-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 100 |
| Experiment ID |
233 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25332113
|
| Organism |
Homo sapiens |
| Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
| Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
| Journal name |
Transfusion
|
| Publication year |
2015 |
| Sample |
Platelets |
| Sample name |
PL-Exs - Rep 3 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation
Optiprep density gradient |
| Flotation density |
1.12-1.15 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 101 |
| Experiment ID |
136 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
PC3 - Rep 2 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 102 |
| Experiment ID |
137 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB6|CD10
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
PC3 - Rep 3 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 103 |
| Experiment ID |
138 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
DU145 - Rep 2 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 104 |
| Experiment ID |
139 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
DU145 - Rep 3 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 105 |
| Experiment ID |
140 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
VCaP - Rep 2 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 106 |
| Experiment ID |
141 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
VCaP - Rep 3 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 107 |
| Experiment ID |
142 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
LNCaP - Rep 2 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 108 |
| Experiment ID |
143 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
LNCaP - Rep 3 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 109 |
| Experiment ID |
144 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
C4-2 - Rep 2 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 110 |
| Experiment ID |
145 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|RAB5|CD10
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
C4-2 - Rep 3 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 111 |
| Experiment ID |
146 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
HSP70|HSP90|CD9
|
Enriched markers |
|
✔
HSP90B1
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
|
| PubMed ID |
22723089
|
| Organism |
Homo sapiens |
| Experiment description |
Prostate cancer cell derived exosomes |
| Authors |
"Hosseini-Beheshti E, Guns ES." |
| Journal name |
MCP
|
| Publication year |
2012 |
| Sample |
Prostate cancer cells |
| Sample name |
RWPE - Rep 2 |
| Isolation/purification methods |
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [QTOF] |
|
|
| 112 |
| Experiment ID |
275 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
|
✔
AIF
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25844599
|
| Organism |
Homo sapiens |
| Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
| Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
| Journal name |
Oncotarget
|
| Publication year |
2015 |
| Sample |
Prostate cancer cells |
| Sample name |
DU145 - Docetaxel sensitive |
| Isolation/purification methods |
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.12-1.19 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry/Flow cytometry/Western blotting |
|
|
| 113 |
| Experiment ID |
274 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
|
✔
AIF
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
25844599
|
| Organism |
Homo sapiens |
| Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
| Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
| Journal name |
Oncotarget
|
| Publication year |
2015 |
| Sample |
Prostate cancer cells |
| Sample name |
DU145 - Docetaxel resistant |
| Isolation/purification methods |
Filtration
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
1.13-1.18 g/mL
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry
Flow cytometry
Western blotting |
|
|
| 114 |
| Experiment ID |
834 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
LAMP2|CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35333565
|
| Organism |
Homo sapiens |
| Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
| Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
| Journal name |
Sci Adv
|
| Publication year |
2022 |
| Sample |
Retinal pigment epithelial cells |
| Sample name |
ARPE-19 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 115 |
| Experiment ID |
835 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
|
✔
CANX
|
Negative markers |
|
✔
NTA
|
Particle analysis
|
|
| Identified molecule |
Protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
35333565
|
| Organism |
Homo sapiens |
| Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
| Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
| Journal name |
Sci Adv
|
| Publication year |
2022 |
| Sample |
Retinal pigment epithelial cells |
| Sample name |
ARPE-19 |
| Isolation/purification methods |
Differential centrifugation
Filtration
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Mass spectrometry |
|
|
| 116 |
| Experiment ID |
64 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Western blotting
|
| PubMed ID |
18520029
|
| Organism |
Homo sapiens |
| Experiment description |
Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. |
| Authors |
"Ogawa Y, Kanai-Azuma M, Akimoto Y, Kawakami H, Yanoshita R" |
| Journal name |
BPB
|
| Publication year |
2008 |
| Sample |
Saliva |
| Sample name |
Saliva |
| Isolation/purification methods |
Filtration
Diafiltration
Gel filtration |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Western blotting
Immunoelectron Microscopy
N-terminal animo acid sequencing |
|
|
| 117 |
| Experiment ID |
66 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
TSG101|Alix|CD63|CD81
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
19199708
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). |
| Authors |
"Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR" |
| Journal name |
JPR
|
| Publication year |
2009 |
| Sample |
Saliva |
| Sample name |
Saliva |
| Isolation/purification methods |
Differential centrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [LTQ]
Western blotting
Immunoelectron Microscopy |
|
|
| 118 |
| Experiment ID |
34 |
| MISEV standards |
|
✔
EM|IEM
|
Biophysical techniques |
|
✔
TSG101|CD63|MHCI|MHCII
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
19190083
|
| Organism |
Homo sapiens |
| Experiment description |
Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. |
| Authors |
"Kesimer M, Scull M, Brighton B, Demaria G, Burns K, O'Neal W, Pickles RJ, Sheehan JK" |
| Journal name |
FASEB
|
| Publication year |
2009 |
| Sample |
Tracheobronchial cells |
| Sample name |
Tracheobronchial epithelial cells |
| Isolation/purification methods |
Differential centrifugation
Filtration
Sucrose density gradient |
| Flotation density |
1.16 -1.18 g/mL
|
| Molecules identified in the study |
Protein
mRNA |
| Methods used in the study |
Mass spectrometry [QTOF]
Western blotting
Immunoelectron Microscopy
FACS |
|
|
| 119 |
| Experiment ID |
13 |
| MISEV standards |
|
✔
IEM
|
Biophysical techniques |
|
✔
Alix|RAB4|RAB5B|RAB11|TSG101|CD9|AQP2|AQP1
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
15326289
|
| Organism |
Homo sapiens |
| Experiment description |
Identification and proteomic profiling of exosomes in human urine. |
| Authors |
"Pisitkun T, Shen RF, Knepper MA" |
| Journal name |
PNAS
|
| Publication year |
2004 |
| Sample |
Urine |
| Sample name |
Urine - Normal |
| Isolation/purification methods |
Ultracentrifugation |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry [LCQ DECA XP]
Western blotting |
|
|
| 120 |
| Experiment ID |
193 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
CD63|CD9
|
Enriched markers |
|
✔
PHB
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Normal |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 121 |
| Experiment ID |
194 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Patients of basement membrane nephropathy |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 122 |
| Experiment ID |
195 |
| MISEV standards |
|
✘
|
Biophysical techniques |
|
✘
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
21595033
|
| Organism |
Homo sapiens |
| Experiment description |
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. |
| Authors |
"Moon PG, Lee JE, You S, Kim TK, Cho JH, Kim IS, Kwon TH, Kim CD, Park SH, Hwang D, Kim YL, Baek MC." |
| Journal name |
Proteomics
|
| Publication year |
2011 |
| Sample |
Urine |
| Sample name |
Urine - Patients of early IgA nephropathy |
| Isolation/purification methods |
Differential centrifugation
Ultracentrifugation
Sucrose density gradient |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 123 |
| Experiment ID |
196 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22418980
|
| Organism |
Homo sapiens |
| Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
| Authors |
"Raj DA, Fiume I, Capasso G, Pocsfalvi G." |
| Journal name |
Kidney Int
|
| Publication year |
2012 |
| Sample |
Urine |
| Sample name |
Urine - Normal high density |
| Isolation/purification methods |
Differential centrifugation
Sucrose cushion |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| 124 |
| Experiment ID |
197 |
| MISEV standards |
|
✔
EM
|
Biophysical techniques |
|
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
|
✘
|
Negative markers |
|
✘
|
Particle analysis
|
|
| Identified molecule |
protein
|
| Identification method |
Mass spectrometry
|
| PubMed ID |
22418980
|
| Organism |
Homo sapiens |
| Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
| Authors |
"Raj DA, Fiume I, Capasso G, Pocsfalvi G." |
| Journal name |
Kidney Int
|
| Publication year |
2012 |
| Sample |
Urine |
| Sample name |
Urine - Normal low density |
| Isolation/purification methods |
Differential centrifugation
Sucrose cushion |
| Flotation density |
-
|
| Molecules identified in the study |
Protein |
| Methods used in the study |
Mass spectrometry |
|
|
| Protein-protein interactions for ACTB |
| |
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
| 1 |
ZSCAN29 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 2 |
ISG15 |
9636 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 3 |
DCTN2 |
10540 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 4 |
PPP1CB |
5500 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 5 |
MBTD1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 6 |
UBL4A |
8266 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 7 |
TK1 |
7083 |
| Two-hybrid |
|
Homo sapiens |
|
| 8 |
MOSPD2 |
158747 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 9 |
RIN3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 10 |
SKI |
6497 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 11 |
ARPC4 |
10093 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 12 |
CRK |
1398 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 13 |
GC |
2638 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 14 |
CAP1 |
10487 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 15 |
DNAJB2 |
3300 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 16 |
EBNA-LP |
|
| Affinity Capture-MS |
|
|
|
| 17 |
MRFAP1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 18 |
NAA50 |
80218 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 19 |
SMARCE1 |
6605 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 20 |
HTR1E |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 21 |
ZZZ3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 22 |
SRGAP2 |
23380 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 23 |
DIAPH1 |
1729 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 24 |
VHL |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
|
| 25 |
AIF1L |
83543 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 26 |
FHOD1 |
29109 |
| Affinity Capture-Western |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| 27 |
SMARCD2 |
6603 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 28 |
NCF1 |
|
| Far Western |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
| Far Western |
|
Homo sapiens |
|
| 29 |
VASP |
7408 |
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 30 |
SH3D19 |
152503 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 31 |
CENPA |
|
| Co-purification |
|
Homo sapiens |
|
| 32 |
HMMR |
|
| Protein-peptide |
|
Homo sapiens |
|
| 33 |
ARPC1A |
10552 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 34 |
APEX1 |
328 |
| Affinity Capture-RNA |
|
Homo sapiens |
|
| 35 |
EFNA3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 36 |
POLH |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 37 |
IGF2BP3 |
10643 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 38 |
WDR76 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 39 |
RASSF8 |
11228 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 40 |
YEATS4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 41 |
ABLIM1 |
3983 |
| Reconstituted Complex |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| 42 |
PALM2-AKAP2 |
445815 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 43 |
COX7A2L |
9167 |
| Co-fractionation |
|
Homo sapiens |
|
| 44 |
ACTR3 |
10096 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 45 |
PPP1R18 |
170954 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 46 |
CALD1 |
800 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 47 |
IL1RL2 |
8808 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 48 |
ASB9 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 49 |
CHMP2B |
25978 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 50 |
RPS9 |
6203 |
| Co-fractionation |
|
Homo sapiens |
|
| 51 |
NUS1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 52 |
PTRH2 |
51651 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 53 |
MARCKSL1 |
65108 |
| Co-fractionation |
|
Homo sapiens |
|
| 54 |
UCHL5 |
51377 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 55 |
SHC1 |
6464 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 56 |
NDUFAB1 |
4706 |
| Co-fractionation |
|
Homo sapiens |
|
| 57 |
MECP2 |
4204 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 58 |
IL23R |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 59 |
KDELC2 |
143888 |
| Co-fractionation |
|
Homo sapiens |
|
| 60 |
WDR5 |
11091 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 61 |
TNKS1BP1 |
85456 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 62 |
SOD1 |
6647 |
| Co-fractionation |
|
Homo sapiens |
|
| 63 |
SIK2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 64 |
SLC25A3 |
5250 |
| Co-fractionation |
|
Homo sapiens |
|
| 65 |
KIF14 |
9928 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 66 |
SORBS1 |
10580 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 67 |
FBXL5 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 68 |
UNK |
|
| Affinity Capture-RNA |
|
Homo sapiens |
|
| 69 |
ZYX |
7791 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 70 |
ALMS1 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 71 |
FGD4 |
121512 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 72 |
ANXA7 |
310 |
| Two-hybrid |
|
Homo sapiens |
|
| 73 |
OR7A17 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 74 |
MTCH2 |
23788 |
| Co-fractionation |
|
Homo sapiens |
|
| 75 |
CDK2 |
1017 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 76 |
RNF4 |
6047 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 77 |
PFN1 |
513895 |
| Co-crystal Structure |
|
Bos taurus |
|
| 78 |
LUZP1 |
7798 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 79 |
MEPCE |
56257 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 80 |
MAP1B |
4131 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 81 |
MTX1 |
4580 |
| Co-fractionation |
|
Homo sapiens |
|
| 82 |
ADA |
100 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 83 |
UBASH3B |
84959 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 84 |
SLC25A20 |
788 |
| Co-fractionation |
|
Homo sapiens |
|
| 85 |
PABPC1 |
26986 |
| Co-fractionation |
|
Homo sapiens |
|
| 86 |
CARM1 |
10498 |
| Co-purification |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 87 |
LRRFIP1 |
9208 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 88 |
YAP1 |
10413 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 89 |
MYH9 |
4627 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 90 |
ACTN4 |
81 |
| Co-fractionation |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| 91 |
OGT |
8473 |
| Reconstituted Complex |
|
Homo sapiens |
|
| 92 |
CBX5 |
23468 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 93 |
TCHP |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 94 |
SCCPDH |
51097 |
| Co-fractionation |
|
Homo sapiens |
|
| 95 |
SYNCRIP |
10492 |
| Co-fractionation |
|
Homo sapiens |
|
| 96 |
CYC1 |
1537 |
| Co-fractionation |
|
Homo sapiens |
|
| 97 |
CCDC22 |
28952 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 98 |
CUL2 |
8453 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 99 |
ACTC1 |
70 |
| Affinity Capture-MS |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 100 |
NCL |
4691 |
| Co-fractionation |
|
Homo sapiens |
|
| 101 |
VDAC2 |
7417 |
| Co-fractionation |
|
Homo sapiens |
|
| 102 |
LARP1B |
55132 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 103 |
IQGAP2 |
10788 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 104 |
SPIRE2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 105 |
MGMT |
4255 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 106 |
MTSS1L |
92154 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 107 |
SCARNA22 |
|
| Affinity Capture-RNA |
|
Homo sapiens |
|
| 108 |
DST |
667 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 109 |
PALM2 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 110 |
HSPA5 |
3309 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 111 |
ARHGAP32 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 112 |
HADHB |
3032 |
| Co-fractionation |
|
Homo sapiens |
|
| 113 |
HADHA |
3030 |
| Co-fractionation |
|
Homo sapiens |
|
| 114 |
MAP4 |
4134 |
| Co-fractionation |
|
Homo sapiens |
|
| 115 |
APOE |
348 |
| Co-fractionation |
|
Homo sapiens |
|
| 116 |
LMNB1 |
4001 |
| Co-fractionation |
|
Homo sapiens |
|
| 117 |
POTEI |
653269 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 118 |
IFI16 |
3428 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 119 |
IQCB1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 120 |
NEBL |
10529 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 121 |
BCAP31 |
10134 |
| Co-fractionation |
|
Homo sapiens |
|
| 122 |
CUL3 |
8452 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 123 |
TOMM22 |
56993 |
| Co-fractionation |
|
Homo sapiens |
|
| 124 |
MTNR1A |
|
| Two-hybrid |
|
Homo sapiens |
|
| 125 |
ATP1B3 |
483 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 126 |
OPRL1 |
4987 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 127 |
FAM187B |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 128 |
FN1 |
2335 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 129 |
PLS1 |
5357 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 130 |
ZW10 |
9183 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 131 |
RPA3 |
6119 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 132 |
EAPP |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 133 |
MAP9 |
79884 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 134 |
CCT8 |
10694 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 135 |
RPL35A |
6165 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 136 |
MYO9B |
4650 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 137 |
HSPA1A |
3303 |
| Co-fractionation |
|
Homo sapiens |
|
| 138 |
FAM21C |
253725 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 139 |
HSPA4 |
3308 |
| Co-fractionation |
|
Homo sapiens |
|
| 140 |
Cct8 |
12469 |
| Reconstituted Complex |
|
Mus musculus |
|
| 141 |
SGTA |
6449 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 142 |
WBP2NL |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 143 |
CTNNA1 |
1495 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 144 |
COX2 |
4513 |
| Co-fractionation |
|
Homo sapiens |
|
| 145 |
AKT1 |
207 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 146 |
HIST1H2AJ |
8331 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 147 |
C6orf132 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 148 |
NADK2 |
133686 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 149 |
MYH11 |
4629 |
| Co-fractionation |
|
Homo sapiens |
|
| 150 |
PFAS |
5198 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 151 |
DUSP19 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 152 |
TMSB10 |
9168 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 153 |
ARPC3 |
10094 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 154 |
CPEB4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 155 |
TP53BP2 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 156 |
TUBGCP2 |
10844 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 157 |
PHACTR2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 158 |
DAB2 |
1601 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 159 |
SHBG |
6462 |
| Two-hybrid |
|
Homo sapiens |
|
| 160 |
DUSP10 |
11221 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 161 |
GRB2 |
2885 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 162 |
USP46 |
64854 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 163 |
PLEC |
5339 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 164 |
SSH1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
|
| 165 |
FABP4 |
2167 |
| Two-hybrid |
|
Homo sapiens |
|
| 166 |
RUVBL2 |
10856 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 167 |
MACF1 |
23499 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 168 |
CKB |
1152 |
| Co-fractionation |
|
Homo sapiens |
|
| 169 |
COX5A |
9377 |
| Co-fractionation |
|
Homo sapiens |
|
| 170 |
SKP1 |
6500 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 171 |
ACTR10 |
55860 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 172 |
YARS |
8565 |
| Co-fractionation |
|
Homo sapiens |
|
| 173 |
MORF4L2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 174 |
FKBP9 |
11328 |
| Co-fractionation |
|
Homo sapiens |
|
| 175 |
ZNF549 |
|
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 176 |
COBLL1 |
22837 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 177 |
NAT6 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 178 |
DNAH5 |
1767 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 179 |
FAM227B |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 180 |
NDUFB9 |
4715 |
| Co-fractionation |
|
Homo sapiens |
|
| 181 |
DYNC1H1 |
1778 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 182 |
SMC3 |
9126 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 183 |
REG3A |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 184 |
RAB2A |
5862 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 185 |
TPST1 |
8460 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 186 |
HNRNPL |
3191 |
| Co-fractionation |
|
Homo sapiens |
|
| 187 |
AIMP2 |
7965 |
| Two-hybrid |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 188 |
RAB11A |
8766 |
| Co-fractionation |
|
Homo sapiens |
|
| 189 |
LIMD1 |
8994 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 190 |
SNW1 |
22938 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 191 |
ESR2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 192 |
VPS72 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 193 |
COG7 |
91949 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 194 |
SMARCC2 |
6601 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 195 |
CTNND1 |
1500 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 196 |
PSMD3 |
5709 |
| Co-fractionation |
|
Homo sapiens |
|
| 197 |
PTPRF |
5792 |
| Affinity Capture-MS |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
|
| 198 |
TUBGCP3 |
10426 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 199 |
SMARCB1 |
6598 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 200 |
LSP1 |
4046 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 201 |
PFDN6 |
10471 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 202 |
LYG2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 203 |
MAGEA3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 204 |
ANP32A |
8125 |
| Co-fractionation |
|
Homo sapiens |
|
| 205 |
FBXL4 |
26235 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 206 |
PAWR |
5074 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 207 |
CCS |
9973 |
| Co-fractionation |
|
Homo sapiens |
|
| 208 |
KCTD10 |
83892 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 209 |
NAA40 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 210 |
RPA2 |
6118 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 211 |
Pparg |
|
| Affinity Capture-MS |
|
Mus musculus |
|
| 212 |
TTR |
7276 |
| Two-hybrid |
|
Homo sapiens |
|
| 213 |
DBN1 |
1627 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| 214 |
MYOC |
4653 |
| Two-hybrid |
|
Homo sapiens |
|
| 215 |
CTTNBP2 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 216 |
DTNA |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 217 |
CORO7 |
79585 |
| Reconstituted Complex |
|
Homo sapiens |
|
| 218 |
HSP90AB1 |
3326 |
| Co-fractionation |
|
Homo sapiens |
|
| 219 |
ROCK2 |
9475 |
| Co-fractionation |
|
Homo sapiens |
|
| 220 |
FMN2 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 221 |
CAND1 |
55832 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 222 |
KIF1B |
23095 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 223 |
RPS3 |
6188 |
| Co-fractionation |
|
Homo sapiens |
|
| 224 |
ATP5L |
10632 |
| Co-fractionation |
|
Homo sapiens |
|
| 225 |
LGALS3BP |
3959 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 226 |
POTEE |
445582 |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 227 |
WTAP |
9589 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 228 |
MBIP |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 229 |
SRCAP |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 230 |
PGK1 |
5230 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 231 |
CORO1B |
57175 |
| Co-fractionation |
|
Homo sapiens |
|
| 232 |
OGDH |
4967 |
| Co-fractionation |
|
Homo sapiens |
|
| 233 |
COPS6 |
10980 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 234 |
HEY1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 235 |
DIAPH3 |
81624 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 236 |
NPM1 |
4869 |
| Co-fractionation |
|
Homo sapiens |
|
| 237 |
ACTR1A |
10121 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 238 |
KHDRBS1 |
10657 |
| Two-hybrid |
|
Homo sapiens |
|
| 239 |
CNN2 |
1265 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 240 |
TINF2 |
|
| Two-hybrid |
|
Homo sapiens |
|
| 241 |
WASH1 |
100287171 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 242 |
LEO1 |
123169 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 243 |
VCAM1 |
7412 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 244 |
DDX6 |
1656 |
| Co-fractionation |
|
Homo sapiens |
|
| 245 |
PFN2 |
5217 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 246 |
PALLD |
23022 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 247 |
CUL1 |
8454 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 248 |
PSMA1 |
5682 |
| Co-fractionation |
|
Homo sapiens |
|
| 249 |
PSAP |
5660 |
| Co-fractionation |
|
Homo sapiens |
|
| 250 |
PLS3 |
5358 |
| Co-fractionation |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| 251 |
YWHAB |
7529 |
| Co-fractionation |
|
Homo sapiens |
|
| 252 |
CCT2 |
10576 |
| Co-crystal Structure |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 253 |
COBL |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 254 |
PFN1 |
5216 |
| Reconstituted Complex |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 255 |
ACTA2 |
59 |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 256 |
PHF10 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 257 |
LCP1 |
3936 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 258 |
HIST1H4A |
8359 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 259 |
TRIM26 |
7726 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 260 |
NFRKB |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 261 |
CDKN1A |
|
| Two-hybrid |
|
Homo sapiens |
|
| 262 |
PHB |
5245 |
| Co-fractionation |
|
Homo sapiens |
|
| 263 |
PEG10 |
23089 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 264 |
NDUFA8 |
4702 |
| Co-fractionation |
|
Homo sapiens |
|
| 265 |
IFNG |
3458 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 266 |
PSMD14 |
10213 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 267 |
CBL |
867 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 268 |
MTX2 |
10651 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 269 |
TAF11 |
|
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 270 |
ADD2 |
119 |
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 271 |
MB21D2 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 272 |
SCGB1A1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 273 |
BCL7C |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 274 |
SIPA1L2 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 275 |
NXF5 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 276 |
GAPDH |
2597 |
| Co-fractionation |
|
Homo sapiens |
|
| 277 |
UQCRC1 |
7384 |
| Co-fractionation |
|
Homo sapiens |
|
| 278 |
CCDC101 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 279 |
MAGOH |
4116 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 280 |
RPLP0 |
6175 |
| Co-fractionation |
|
Homo sapiens |
|
| 281 |
UPK1A |
11045 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 282 |
AGPS |
8540 |
| Co-fractionation |
|
Homo sapiens |
|
| 283 |
CYBB |
1536 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 284 |
LUCAT1 |
|
| Affinity Capture-RNA |
|
Homo sapiens |
|
| 285 |
FBXO5 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 286 |
CCDC25 |
55246 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 287 |
PLEKHG6 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 288 |
HNRNPD |
3184 |
| Two-hybrid |
|
Homo sapiens |
|
| 289 |
ALDH7A1 |
501 |
| Co-fractionation |
|
Homo sapiens |
|
| 290 |
PTPN11 |
5781 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 291 |
DIP2B |
57609 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 292 |
ABI1 |
10006 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 293 |
PSMA3 |
5684 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 294 |
AIFM1 |
9131 |
| Co-fractionation |
|
Homo sapiens |
|
| 295 |
FLNA |
2316 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 296 |
ICAM1 |
3383 |
| Co-fractionation |
|
Homo sapiens |
|
| 297 |
Cct5 |
12465 |
| Reconstituted Complex |
|
Mus musculus |
|
| 298 |
ARPC1B |
10095 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 299 |
TBCE |
6905 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 300 |
UBXN7 |
26043 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 301 |
BRD8 |
10902 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 302 |
TJP1 |
7082 |
| Affinity Capture-MS |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| 303 |
CSRP2BP |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 304 |
EGFR |
1956 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 305 |
FBXO30 |
84085 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 306 |
FUS |
2521 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 307 |
MTFR1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 308 |
METTL3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 309 |
MORF4L1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 310 |
HOMER1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 311 |
SPTBN1 |
6711 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 312 |
ARFIP1 |
27236 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 313 |
YWHAQ |
10971 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 314 |
RPS27 |
6232 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 315 |
DMAP1 |
55929 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 316 |
CEP250 |
11190 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 317 |
ZMYM6 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 318 |
MYC |
|
| Co-purification |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 319 |
UBASH3A |
53347 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 320 |
SFXN5 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 321 |
EP400 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 322 |
TMOD2 |
29767 |
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 323 |
TMOD3 |
29766 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 324 |
JMY |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 325 |
DAAM1 |
23002 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 326 |
EEF1A2 |
1917 |
| Co-fractionation |
|
Homo sapiens |
|
| 327 |
ACTR8 |
93973 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 328 |
DSTN |
11034 |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 329 |
FAM107B |
83641 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 330 |
MPRIP |
23164 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 331 |
CDK10 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 332 |
LMNA |
4000 |
| Co-fractionation |
|
Homo sapiens |
|
| 333 |
2510003E04Rik |
|
| Affinity Capture-MS |
|
Mus musculus |
|
| 334 |
PHGDH |
26227 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 335 |
EIF3H |
8667 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 336 |
MTA2 |
9219 |
| Co-fractionation |
|
Homo sapiens |
|
| 337 |
PA2G4 |
5036 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 338 |
KIAA0100 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 339 |
KRT18 |
3875 |
| Co-fractionation |
|
Homo sapiens |
|
| 340 |
UBE3A |
7337 |
| Reconstituted Complex |
|
Homo sapiens |
|
| 341 |
PSMB10 |
5699 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 342 |
PARP1 |
142 |
| Co-fractionation |
|
Homo sapiens |
|
| 343 |
WIPF3 |
|
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 344 |
TP53 |
7157 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 345 |
FOLR1 |
2348 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 346 |
Cdk9 |
|
| Affinity Capture-Western |
|
Mus musculus |
|
| 347 |
HDAC6 |
10013 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 348 |
CLEC2D |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 349 |
Myo1c |
17913 |
| Affinity Capture-MS |
|
Mus musculus |
|
| 350 |
SIPA1L3 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 351 |
ARPC2 |
10109 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 352 |
CAPZA2 |
830 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 353 |
RPAP2 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 354 |
GPR3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 355 |
CXorf21 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 356 |
PNMA1 |
9240 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 357 |
OTUB1 |
55611 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 358 |
KLHL7 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 359 |
ESR1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 360 |
DDX39A |
10212 |
| Co-fractionation |
|
Homo sapiens |
|
| 361 |
ABI2 |
10152 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 362 |
BCL2L1 |
598 |
| Two-hybrid |
|
Homo sapiens |
|
| 363 |
ERRFI1 |
54206 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 364 |
PHACTR3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 365 |
ZNF284 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 366 |
OSTF1 |
26578 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 367 |
EP300 |
2033 |
| Affinity Capture-MS |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
|
| 368 |
ATP5C1 |
509 |
| Co-fractionation |
|
Homo sapiens |
|
| 369 |
PAFAH1B1 |
5048 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 370 |
IFIT1 |
3434 |
| Co-fractionation |
|
Homo sapiens |
|
| 371 |
SSH2 |
|
| Reconstituted Complex |
|
Homo sapiens |
|
| 372 |
PRMT1 |
3276 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 373 |
HSD17B3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 374 |
CC2D1A |
54862 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 375 |
TCP1 |
6950 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 376 |
COTL1 |
23406 |
| Reconstituted Complex |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
|
| 377 |
ATP6V1B2 |
526 |
| Co-fractionation |
|
Homo sapiens |
|
| 378 |
UBE2H |
7328 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 379 |
HNRNPC |
3183 |
| Co-fractionation |
|
Homo sapiens |
|
| 380 |
PPIAL4G |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 381 |
RAB1A |
5861 |
| Co-fractionation |
|
Homo sapiens |
|
| 382 |
DBNL |
28988 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 383 |
WIPF2 |
147179 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 384 |
NDUFS1 |
4719 |
| Co-fractionation |
|
Homo sapiens |
|
| 385 |
PTMA |
5757 |
| Co-fractionation |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 386 |
THRB |
7068 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 387 |
WASF2 |
10163 |
| Proximity Label-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 388 |
ACTR2 |
10097 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 389 |
YWHAE |
7531 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 390 |
TRIM58 |
25893 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 391 |
LIMCH1 |
22998 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 392 |
EPS15 |
2060 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 393 |
CCT3 |
7203 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 394 |
LMX1B |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 395 |
ADD3 |
120 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 396 |
UQCRB |
7381 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 397 |
EPS8 |
2059 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 398 |
SSB |
6741 |
| Co-fractionation |
|
Homo sapiens |
|
| 399 |
HNRNPR |
10236 |
| Co-fractionation |
|
Homo sapiens |
|
| 400 |
PSMD10 |
5716 |
| Co-fractionation |
|
Homo sapiens |
|
| 401 |
PTPN1 |
5770 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 402 |
NCKAP1 |
10787 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 403 |
RAPH1 |
65059 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 404 |
MOK |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 405 |
CAPZB |
832 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 406 |
GLYATL1 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 407 |
RPL10A |
4736 |
| Two-hybrid |
|
Homo sapiens |
|
| 408 |
RUVBL1 |
8607 |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 409 |
RDX |
5962 |
| Co-fractionation |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| 410 |
NDUFS3 |
4722 |
| Co-fractionation |
|
Homo sapiens |
|
| 411 |
WASH3P |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 412 |
PFN3 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 413 |
NUMBL |
9253 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 414 |
NFE2L2 |
4780 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 415 |
LASP1 |
3927 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 416 |
IQGAP1 |
8826 |
| Affinity Capture-Western |
|
Homo sapiens |
| Co-localization |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Co-fractionation |
|
Homo sapiens |
|
| 417 |
CAPZA1 |
829 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 418 |
LPP |
4026 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 419 |
PGD |
5226 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 420 |
RCC1 |
1104 |
| Two-hybrid |
|
Homo sapiens |
|
| 421 |
ITGA4 |
3676 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 422 |
WDR44 |
54521 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 423 |
NDUFV1 |
4723 |
| Co-fractionation |
|
Homo sapiens |
|
| 424 |
YEATS2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 425 |
RAB8B |
51762 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 426 |
TFCP2 |
7024 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 427 |
CSNK2B |
1460 |
| Two-hybrid |
|
Homo sapiens |
|
| 428 |
STAT6 |
6778 |
| Co-fractionation |
|
Homo sapiens |
|
| 429 |
CYLD |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 430 |
GPRIN1 |
114787 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 431 |
NDUFS5 |
4725 |
| Co-fractionation |
|
Homo sapiens |
|
| 432 |
ARHGAP27 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 433 |
HSPA8 |
3312 |
| Co-fractionation |
|
Homo sapiens |
|
| 434 |
SAMHD1 |
25939 |
| Reconstituted Complex |
|
Homo sapiens |
|
| 435 |
TSHR |
7253 |
| Two-hybrid |
|
Homo sapiens |
|
| 436 |
MYO18A |
399687 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 437 |
ATP5A1 |
498 |
| Co-fractionation |
|
Homo sapiens |
|
| 438 |
SPTB |
6710 |
| Reconstituted Complex |
|
Homo sapiens |
|
| 439 |
KIAA1211 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 440 |
SUCLG1 |
8802 |
| Co-fractionation |
|
Homo sapiens |
|
| 441 |
RAC2 |
5880 |
| Far Western |
|
Homo sapiens |
|
| 442 |
PARK2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 443 |
DCTN5 |
84516 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 444 |
DIXDC1 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 445 |
CCT6A |
908 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 446 |
SIPA1L1 |
26037 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 447 |
NCALD |
83988 |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 448 |
PAM16 |
|
| Co-fractionation |
|
Homo sapiens |
|
| 449 |
PLOD2 |
5352 |
| Co-fractionation |
|
Homo sapiens |
|
| 450 |
MAPT |
|
| Reconstituted Complex |
|
Homo sapiens |
|
| 451 |
BTF3 |
689 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 452 |
MSN |
4478 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 453 |
ANKHD1-EIF4EBP3 |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 454 |
DPF2 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 455 |
ARFGAP2 |
84364 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 456 |
FBXO40 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 457 |
U2AF2 |
11338 |
| Co-fractionation |
|
Homo sapiens |
|
| 458 |
OCIAD2 |
132299 |
| Co-fractionation |
|
Homo sapiens |
|
| 459 |
ACTB |
60 |
| Two-hybrid |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Reconstituted Complex |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
|
| 460 |
DHX9 |
1660 |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
|
| 461 |
TECR |
9524 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 462 |
VCPIP1 |
80124 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 463 |
ATF3 |
|
| Affinity Capture-Western |
|
Homo sapiens |
|
| 464 |
ACTG1 |
71 |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Two-hybrid |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 465 |
ARHGAP17 |
55114 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 466 |
TRIM21 |
6737 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 467 |
SVIL |
6840 |
| Co-fractionation |
|
Homo sapiens |
| Proximity Label-MS |
|
Homo sapiens |
|
| 468 |
SLX4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 469 |
AQP2 |
359 |
| Two-hybrid |
|
Homo sapiens |
|
| 470 |
EFNA4 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 471 |
AHCY |
191 |
| Co-fractionation |
|
Homo sapiens |
|
| 472 |
METTL14 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 473 |
BAZ1B |
9031 |
| Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
| 474 |
RPL15 |
6138 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 475 |
SMARCD1 |
6602 |
| Affinity Capture-MS |
|
Homo sapiens |
|
| 476 |
FAM60A |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 477 |
HOXB5 |
|
| Affinity Capture-MS |
|
Homo sapiens |
|
| 478 |
TRAF3IP1 |
26146 |
| Affinity Capture-MS |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Affinity Capture-Western |
|
Homo sapiens |
| Co-localization |
|
Homo sapiens |
|
| 479 |
ANXA5 |
308 |
| Co-fractionation |
|
Homo sapiens |
|
| 480 |
FAM21A |
387680 |
| Proximity Label-MS |
|
Homo sapiens |
|
| 481 |
CCDC85C |
|
| Proximity Label-MS |
|
Homo sapiens |
|
| 482 |
TFPT |
|
| | | |